Related Experiment Video
Updated: Mar 25, 2026
09:43
Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
Published on: August 10, 2015
16.6K
Current Cell-Based Strategies for Whole Kidney Regeneration
Nafiseh Poornejad1, Lara B Schaumann1, Evan M Buckmiller2
11 Department of Chemical Engineering, Brigham Young University , Provo, Utah.
Tissue Engineering. Part B, Reviews
|February 25, 2016
Summary
Bioengineered kidneys offer a promising solution for end-stage renal failure, potentially overcoming donor shortages and immune rejection issues associated with transplantation. This review explores current bioengineering strategies and their challenges.
Area of Science:
- Regenerative Medicine
- Biotechnology
- Nephrology
Background:
- Chronic kidney diseases impact global health, with hemodialysis offering limited function replacement.
- Orthotopic kidney transplantation is the definitive treatment but faces donor scarcity and lifelong immunosuppression challenges.
- Current transplantation methods have limitations, including organ rejection and reduced recipient life expectancy.
Purpose of the Study:
- To review and analyze various bioengineering strategies for creating patient-specific kidneys.
- To discuss the advantages and disadvantages of current bioengineering approaches.
- To identify unresolved challenges in the field of kidney bioengineering.
Main Methods:
- Review of recent scientific literature on kidney bioengineering techniques.
- Analysis of strategies including scaffold repopulation, de novo generation using induced pluripotent stem cells, and in-embryo creation.
- Evaluation of the pros, cons, and current limitations of each method.
Main Results:
- Bioengineering offers potential for inexhaustible, patient-specific kidneys, avoiding immune rejection.
- Strategies reviewed include scaffold-based regeneration, stem cell differentiation, and xenogenesis.
- Significant challenges remain in achieving full kidney function and clinical viability.
Conclusions:
- Patient-specific bioengineered kidneys present a viable alternative to traditional transplantation.
- Further research is needed to address technical hurdles and ensure long-term efficacy.
- Advancements in regenerative medicine hold promise for revolutionizing kidney disease treatment.
